Vitadio offers human-assisted digital therapeutics for prevention/management of cardiometabolic diseases using data-driven behavioral change
Vitadio offers data-driven behavioural intervention employing a highly successful hybrid approach that combines automated interactions with well-timed human support. We emulate a continuous guidance of a multidisciplinary team and provide proactive psychological support when the patient needs it the most. Vitadio tackles nutrition, physical activity, mental wellbeing, motivation and medical education. It integrates physicians into the patient journey and complements medication treatment. Seamless user experience and proactive personalized support lead to significant improvement in metabolic parameters (as shown by an RCT and real-world evidence) and 83% retention after 3 months (3x industry average).
Vitadio is a CE-certified medical device (class I), it is compliant with GDPR and local data protection laws, it has implemented information security management system and quality management according to ISO 13485, and the content of the app is in line with official medical guidelines.
Accelerate growth on European markets through.
Uniqa, Debeka, AstraZeneca, Boehringer Ingelheim, Novo Nordisk